Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02PMT
|
|||
Former ID |
DIB010338
|
|||
Drug Name |
Nagrestipen
|
|||
Synonyms |
EMIP; BB-10010; ECI-301; Macrophage inflammatory protein 1a, British Biotech; Stem cell protector, British Biotech; MIP-1a, British Biotech; MIP-1 alpha derivatives (cancer), Effector
Click to Show/Hide
|
|||
Indication | Bone marrow transplantation [ICD-11: QB63.6; ICD-9: 279.5, 996] | Phase 1 | [1] | |
Company |
Vernalis plc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Macrophage inflammatory protein 1-alpha (CCL3) | Target Info | Modulator | [1] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
Toll-like receptor signaling pathway | ||||
Salmonella infection | ||||
Chagas disease (American trypanosomiasis) | ||||
Rheumatoid arthritis | ||||
NetPath Pathway | IL9 Signaling Pathway | |||
IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | ||||
TWEAK Signaling Pathway | ||||
RANKL Signaling Pathway | ||||
TCR Signaling Pathway | ||||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
Pathway Interaction Database | IL12-mediated signaling events | |||
Reactome | Chemokine receptors bind chemokines | |||
WikiPathways | Toll-like receptor signaling pathway | |||
Senescence and Autophagy in Cancer | ||||
GPCR ligand binding | ||||
Regulation of toll-like receptor signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Macrophage inflammatory protein derivative ECI301 enhances the alarmin-associated abscopal benefits of tumor radiotherapy. Cancer Res. 2014 Sep 15;74(18):5070-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.